Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf حسب Aline Freyssin (11912204)

"…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …"

Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf حسب Aline Freyssin (11912204)

"…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …"

Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf حسب Aline Freyssin (11912204)

"…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …"

Risk-taking behavior identified by the BART decreases after acclimatization. حسب Erica C. Heinrich (6832055)

Previous PMC-PTB group comparing 17P treated population vs. untreated. حسب Gal Cohen (12536546)

الموضوعات:

This is the raw data of our study cohort, with no identifiers. حسب Gal Cohen (12536546)

الموضوعات:

Previous pPROM-PTB group comparing 17P treated population vs. untreated. حسب Gal Cohen (12536546)

الموضوعات:

Flowchart describing the study population. حسب Gal Cohen (12536546)

الموضوعات:

Previous PTB PMC vs. previous pPROM. حسب Gal Cohen (12536546)

الموضوعات:

Health assessment questions. حسب Tamara M. Masters (14094156)

الموضوعات:

Forest plot of mouse movement time z scores by treatment and gender. حسب Tamara M. Masters (14094156)

الموضوعات:

Mouse tracking time and distance to final response (z score). حسب Tamara M. Masters (14094156)

الموضوعات:

Statements for treatments. حسب Tamara M. Masters (14094156)

الموضوعات:

Forest plot of mouse movement distance z score by treatment and gender. حسب Tamara M. Masters (14094156)

الموضوعات:

Forest plot of answer adjustment by treatment and gender. حسب Tamara M. Masters (14094156)

الموضوعات:

Answer adjustment measures (abs) by treatment for combined questions: Weight, EtOH, drugs, OD, smoke, exercise, sex. حسب Tamara M. Masters (14094156)

الموضوعات:

Count of individuals randomly assigned to each condition. حسب Tamara M. Masters (14094156)

الموضوعات:

The trend of patient characteristics, risk factors, and risk scores. حسب Ayako Shoji (78037)

Burials <i>in situ</i> at the cemetery in Wtórek, Greater Poland, Poland. حسب Agata Hałuszko (13608045)

Risk of fracture with competing risk in denosumab users versus non-users. حسب Arisa Kobayashi (4379608)

الموضوعات: